durvalumab,Tremelimumab
AstraZeneca
$azn astrazeneca shares data at easl and esmo world gi for imfinzi (durvalumab) combinations in patients with liver and biliary tract cancers 
Be the First to Know Which #PennyStocks Are Being Promoted - Not the Last! Real-Time #StockAlert Tracking and Monitoring: https://t.co/WLRj8z0R5p